Patents by Inventor Terrance L. Fox

Terrance L. Fox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for basal cell carcinoma
    Patent number: 8835394
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: September 16, 2014
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Method of treating actinic keratosis
    Patent number: 8354424
    Abstract: A method of treating actinic keratosis including applying topically to an actinic keratosis lesion twice per week for a duration of 8 weeks a formulation comprising 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: January 15, 2013
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: James H. Lee, Terrance L. Fox
  • TREATMENT FOR BASAL CELL CARCINOMA
    Publication number: 20120035205
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: October 18, 2011
    Publication date: February 9, 2012
    Applicant: Graceway Pharmaceuticals. LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Treatment for basal cell carcinoma
    Publication number: 20100197722
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: April 2, 2010
    Publication date: August 5, 2010
    Applicant: Graceway Pharmaceuticals, LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • METHODS FOR DIAGNOSING SKIN LESIONS
    Publication number: 20100180902
    Abstract: Methods for diagnosing skin lesions are disclosed. Generally, the method include topically administering an IRM compound to a treatment area for a period of time and in an amount effective to cause a visible change in the appearance of a skin lesion including, in some cases, causing subclinical lesions to become visible. Suitable IRM compounds include agonists of one or more TLRs.
    Type: Application
    Filed: March 17, 2010
    Publication date: July 22, 2010
    Inventors: Richard L. Miller, James H. Lee, Terrance L. Fox
  • Methods for treating skin lesions
    Patent number: 7699057
    Abstract: Methods for diagnosing skin lesions are disclosed. Generally, the method include topically administering an IRM compound to a treatment area for a period of time and in an amount effective to cause a visible change in the appearance of a skin lesion including, in some cases, causing subclinical lesions to become visible. Suitable IRM compounds include agonists of one or more TLRs.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 20, 2010
    Assignee: 3M Innovative Properties Company
    Inventors: Richard L. Miller, James H. Lee, Terrance L. Fox
  • Treatment for basal cell carcinoma
    Patent number: 7696159
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: April 13, 2010
    Assignee: Graceway Pharmaceuticals, LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Method of Treating Actinic Keratosis
    Publication number: 20080262022
    Abstract: A method of treating actinic keratosis including applying topically to an actinic keratosis lesion twice per week for a duration of 8 weeks a formulation comprising 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.
    Type: Application
    Filed: March 14, 2006
    Publication date: October 23, 2008
    Applicant: Graceway Phamaceuticals LLC
    Inventors: James H. Lee, Terrance L. Fox
  • Treatment for basal cell carcinoma
    Publication number: 20040192585
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 30, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Methods for diagnosing skin lesions
    Publication number: 20040181130
    Abstract: Methods for diagnosing skin lesions are disclosed. Generally, the method include topically administering an IRM compound to a treatment area for a period of time and in an amount effective to cause a visible change in the appearance of a skin lesion including, in some cases, causing subclinical lesions to become visible. Suitable IRM compounds include agonists of one or more TLRs.
    Type: Application
    Filed: March 12, 2004
    Publication date: September 16, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Richard L. Miller, James H. Lee, Terrance L. Fox